Prospective cost-effectiveness analysis of genomic profiling in breast cancer

Valesca P. Retel, M. A. Joore, C. A. Drukker, J. M. Bueno-de-Mesquita, M. Knauer, H. van Tinteren, S.C. Linn, Wim H. van Harten

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3773-3779
JournalEuropean Journal of Cancer
Volume49
Issue number18
DOIs
Publication statusPublished - Dec 2013

Keywords

  • Breast cancer
  • Gene expression profiling
  • Adjuvant systemic treatment
  • Real world cost-effectiveness

Cite this

Retel, V. P., Joore, M. A., Drukker, C. A., Bueno-de-Mesquita, J. M., Knauer, M., van Tinteren, H., Linn, S. C., & van Harten, W. H. (2013). Prospective cost-effectiveness analysis of genomic profiling in breast cancer. European Journal of Cancer, 49(18), 3773-3779. https://doi.org/10.1016/j.ejca.2013.08.001